Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 12.5B | 17.2B | 16.2B | 11.9B |
Cost of revenue | 4.1B | 6.2B | 5.6B | 3.9B |
Gross profit | 8.4B | 11.0B | 10.7B | 8.0B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 3.9B | 4.0B | 4.1B | 3.9B |
Operating income | -330M | 2.1B | 1.5B | -627M |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 2.0B | 2.0B | 2.1B | 2.0B |
Other income expense | — | — | — | — |
Pretax income | -1.7B | 462M | -147M | -2.4B |
Tax provision | -424M | 107M | -26M | -591M |
Net income | -1.3B | 355M | -121M | -1.8B |
Basic EPS | — | 3.7 | -1.2 | -18.2 |
Diluted EPS | — | 3.7 | -1.2 | -18.2 |
Basic average shares | — | 98.1M | 98.3M | 98.1M |
Diluted average shares | — | 98.1M | 98.3M | 98.1M |
EBITDA | 3.4B | 5.7B | 5.2B | 2.8B |
Net income from continuing op. | — | — | — | — |
Minority interests | 3M | 4M | 3M | 3M |
Preferred stock dividends | 0 | 0 | 0 | 0 |